About
Komathi Stem is a pharmaceutical and health IT executive with over 30 years of experience in drug development and healthcare technology. She has held leadership positions at companies including Eli Lilly, AstraZeneca, and Genentech, managing R&D and commercial functions with P&L responsibilities exceeding $50M across oncology, endocrine, cardio-metabolic, and other therapeutic domains. Stem co-founded Science 37 and monARC Bionetworks, which together raised over $150M in funding, and currently serves as Strategic Advisor at Oncoustics.
Experience
- OncousticsStrategic Advisorcurrent2021 — presentSan Francisco Bay Area
- ReThynk ConsultingChief Executive Officercurrent2016 — presentPalo Alto, California, United States
- CoPeaceBoard Membercurrent2018 — presentDenver, Colorado, United States
- GlookoChief Operating Officer2020 — 2024Palo Alto, CA
- monARC Bionetworks, Inc.Founder and CEO2016 — 2019Palo Alto, CA
- GenentechStrategic Innovation Consultant2016 — 2017
- GenentechSr. Director, Product Development2006 — 2016South San Francisco
- Science 37, Inc.Chief Operating Officer and Strategic Advisor2014 — 2016Los Angeles Metropolitan Area
- AstraZenecaSr. Director2003 — 2006
- Eli Lilly and CompanyVariety of Positions1992 — 2003Indianapolis
Education
- University of VirginiaMaster's degree, Biomedical/Medical Engineering1990 — 1992
- University of VirginiaMA, Biomedical Engineering1990 — 1992
- St. Olaf CollegeBachelor of Science (BS), Mathematics1983 — 1987
Skills & more
Patient RecruitmentHuman Resources (HR)Strategic LeadershipResearch and Development (R&D)Strategic PartnershipsLeadershipBoard of DirectorsPatient AdvocacyBiopharmaceuticalsBusiness StrategyKey MetricsFinancial Modeling
+12 more
FinancePatient EngagementDigital StrategyAI/ML SolutionsCorporate StrategyCreativity and InnovationDecentralized clinical trialsRemote Patient MonitoringCTMSClinical Trial Management System (CTMS)Product DevelopmentRegulatory AffairsLanguages Tamil
From Komathi's professional profile.
Same school
Also attended University of Virginia316
Alexis OhanianFounder & General Partner of Seven Seven SixAndy FligelSenior Managing Director at Intel CapitalKandace ElamVice President of GTM Talent at Menlo VenturesTrevor KienzleInvestor at Correlation VenturesFrank RotmanCo-Founder and Partner Emeritus at QED InvestorsMegan LightcapPartner, Creator Fund at Slow Ventures
+ 310 more
Also attended St. Olaf College8
Galen MasonManaging Director at Service Provider CapitalMargo HaysSenior Advisor at TSG Consumer PartnersTyler HayesPrincipal at Thuja CapitalStuart MasonAdvisor at Transpose Platform ManagementAllison BoxerManaging Director & Academic Lecturer at Sorenson ImpactLaya Hess-SkinnerDevelopment Director at NESsT
_edited.jpg)
+ 2 more
Shared employers
Also worked at Oncoustics1
Also worked at Glooko4
Also worked at Genentech89
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Marco PrunottoInvestor at MedicxiLogan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock Ventures
+ 83 more
Also worked at Science 37, Inc.1
Colleagues at CoPeace Capital
Andy Eckert
COO at CoPeace Capital
Barbara Winter
Impact Director at CoPeace Capital
Betsy Poell
Advisory Council at CoPeace Capital
Brad Tompkins
Board of Directors at CoPeace Capital
Craig Jonas
CEO and Founder at CoPeace Capital
Craig Jonas, Ph.D.
Founder & CEO at CoPeace Capital
Dan Hattori
Strategic Financial Advisor at CoPeace Capital
Derek Scott
Vice President of Marketing at CoPeace Capital